Haotian Wang

1.8k citations
75 papers · 1.2k indexed · 1 hit paper · h-index 16
Topics
RNA modifications and cancer (5 papers)Lymphoma Diagnosis and Treatment (5 papers)Microbial Natural Products and Biosynthesis (5 papers)

In The Last Decade

Haotian Wang

69 papers receiving 1.2k citations

Hit Papers

Can N95 Respirators Be Reused after Disinfection? How Man...20202026202220242020100200300

Peers

Haotian Wang
Comparison fields: 5 of 141
  • Pulmonary and Respiratory Medicine 475
  • Molecular Biology 351
  • Oncology 218
  • Biomedical Engineering 144
  • Electrical and Electronic Engineering 133
Replace Heyi Li with:
Heyi Li China
Yao Chen China
Zdeněk Fiala Czechia
Yang Bai China
Habiba Alsafar United Arab Emirates
Alessandra Pulliero Italy
Ran Qin China
Minghui Liu China
Haotian Wang relative to Heyi Li China Heyi Li's profile →
Citations per field
00.5×5.5×
Heyi Li · 1×
Citations per year

Countries citing papers authored by Haotian Wang

Since Specialization
Citations

This map shows the geographic impact of Haotian Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haotian Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haotian Wang more than expected).

Fields of papers citing papers by Haotian Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haotian Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haotian Wang. The network helps show where Haotian Wang may publish in the future.

Co-authorship network of co-authors of Haotian Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Haotian Wang. A scholar is included among the top collaborators of Haotian Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haotian Wang. Haotian Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 0
4 0
5 1
6 9
7 1
8 0
9 1
10 0
11 13
12 5
13 37
14 25
15 22
16 42
17 90
18 12
19 24
20 4

About Haotian Wang

Haotian Wang is a scholar working on Cancer Research, Architecture and Equine, having authored 75 papers that have together received 1.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Microbial Natural Products and Biosynthesis (5 papers). The work is most often cited by research in General Dentistry (31 citations), Pulmonary and Respiratory Medicine (475 citations) and Aging (22 citations). Haotian Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Qiqi Wang, Xiao Wang, Mervin Zhao, Steven Chu, Lei Liao, Yi Cui, Fu‐Hui Xiao, Qing‐Peng Kong, Amy Price and Larry F. Chu. Their work appears in journals such as Nature, Journal of the American Chemical Society and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026